{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T09:55:58Z","timestamp":1756461358710},"reference-count":7,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,6,23]]},"DOI":"10.7759\/cureus.26269","type":"journal-article","created":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T03:58:27Z","timestamp":1656043107000},"source":"Crossref","is-referenced-by-count":2,"title":["Bilateral Orbital Plasmacytomas With Orbital Compartment Syndrome"],"prefix":"10.7759","author":[{"given":"Rachel E","family":"Pyon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace C","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil","family":"Tulpule","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Plasma cell neoplasms (including multiple myeloma) treatment [PDQ(R)]. (2002). Accessed. June 9, 2022: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK82221\/."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-017-0549-1","article-title":"Diagnosis, treatment, and response assessment in solitary plasmacytoma: updated recommendations from a European Expert Panel","volume":"11","author":"Caers J","year":"2018","unstructured":"Caers J, Paiva B, Zamagni E, et al.. Diagnosis, treatment, and response assessment in solitary plasmacytoma: updated recommendations from a European Expert Panel. J Hematol Oncol. 2018, 11:10. 10.1186\/s13045-017-0549-1","journal-title":"J Hematol Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.5152\/tjh.2010.01","article-title":"Radiation therapy for the solitary plasmacytoma","volume":"27","author":"Ko\u00e7ak E","year":"2010","unstructured":"Ko\u00e7ak E, Ballerini G, Zouhair A, \u00d6z\u015fahin M. Radiation therapy for the solitary plasmacytoma. Turk J Haematol. 2010, 27:57-61. 10.5152\/tjh.2010.01","journal-title":"Turk J Haematol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2147\/IMCRJ.S260472","article-title":"Bilateral proptosis in a case of recurring multiple myeloma: uncommon orbital presentation of plasmacytoma","volume":"13","author":"Barmas-Alamdari D","year":"2020","unstructured":"Barmas-Alamdari D, Sodhi GS, Shenouda TA. Bilateral proptosis in a case of recurring multiple myeloma: uncommon orbital presentation of plasmacytoma. Int Med Case Rep J. 2020, 13:297-301. 10.2147\/IMCRJ.S260472","journal-title":"Int Med Case Rep J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2009.04.012","article-title":"Characteristics of orbital multiple myeloma: a case report and literature review","volume":"54","author":"Burkat CN","year":"2009","unstructured":"Burkat CN, Van Buren JJ, Lucarelli MJ. Characteristics of orbital multiple myeloma: a case report and literature review. Surv Ophthalmol. 2009, 54:697-704. 10.1016\/j.survophthal.2009.04.012","journal-title":"Surv Ophthalmol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdp329","article-title":"Incidence, presenting features and outcome of extramedullary disease in multiple myeloma: a longitudinal study on 1003 consecutive patients","volume":"21","author":"Varettoni M","year":"2010","unstructured":"Varettoni M, Corso A, Pica G, Mangiacavalli S, Pascutto C, Lazzarino M. Incidence, presenting features and outcome of extramedullary disease in multiple myeloma: a longitudinal study on 1003 consecutive patients. Ann Oncol. 2010, 21:325-30. 10.1093\/annonc\/mdp329","journal-title":"Ann Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.13046","article-title":"Daratumumab resistance is frequent in advanced-stage multiple myeloma patients irrespective of CD38 expression and is related to dismal prognosis","volume":"100","author":"Pick M","year":"2018","unstructured":"Pick M, Vainstein V, Goldschmidt N, et al.. Daratumumab resistance is frequent in advanced-stage multiple myeloma patients irrespective of CD38 expression and is related to dismal prognosis. Eur J Haematol. 2018, 100:494-501. 10.1111\/ejh.13046","journal-title":"Eur J Haematol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/77231-bilateral-orbital-plasmacytomas-with-orbital-compartment-syndrome","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:38:30Z","timestamp":1707507510000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/77231-bilateral-orbital-plasmacytomas-with-orbital-compartment-syndrome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,23]]},"references-count":7,"URL":"https:\/\/doi.org\/10.7759\/cureus.26269","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6,23]]}}}